Heat Biologics, Inc.
INTRATUMORAL VACCINATION
Last updated:
Abstract:
The present disclosure relates to, inter alia, a method for treating a tumor by intratumorally delivering an effective amount of a composition comprising an expression vector that comprises a first nucleotide sequence encoding a secretable vaccine protein, and a second nucleotide sequence encoding a T cell costimulatory fusion protein.
Status:
Application
Type:
Utility
Filling date:
3 Apr 2018
Issue date:
30 Jan 2020